UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1049-1056

2015

Volltextzugriff (PDF)

Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation

Lung cancer (Amsterdam, Netherlands), 2007-01, Vol.55 (1), p.1-14

2007

Volltextzugriff (PDF)

Comparison between opportunistic and organised breast cancer mammography screening in the Swiss canton of Fribourg

BMC cancer, 2019-05, Vol.19 (1), p.469-8, Article 469

2019

Volltextzugriff (PDF)

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4157-4164

2004

Volltextzugriff (PDF)

Swiss Delphi study on iron deficiency

Swiss medical weekly, 2019-07, Vol.149, p.w20097

2019

Volltextzugriff (PDF)

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1752-1759

2003

Volltextzugriff (PDF)

Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)

Journal of thoracic oncology, 2019-01, Vol.14 (1), p.115-123

2019

Volltextzugriff (PDF)

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Journal of clinical oncology, 2005-02, Vol.23 (4), p.705-711

2005

Volltextzugriff (PDF)

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer

The Annals of thoracic surgery, 2005-07, Vol.80 (1), p.268-275

2005

Volltextzugriff (PDF)

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Swiss medical weekly, 2019-04, Vol.149, p.w20031

2019

Volltextzugriff (PDF)

Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2831-2839

2005

Volltextzugriff (PDF)

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.881-889

2019

Volltextzugriff (PDF)

Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)

Clinical cancer research, 2012-11, Vol.18 (21), p.6049-6057

2012

Volltextzugriff (PDF)

A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.81-84

2013

Volltextzugriff (PDF)

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

Supportive care in cancer, 2013-09, Vol.21 (9), p.2565-2573

2013

Volltextzugriff (PDF)

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

Journal of Oncology, 2014-01, Vol.2014 (2014), p.1-6

2014

Volltextzugriff (PDF)

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2011-03, Vol.71 (3), p.306-311

2011

Volltextzugriff (PDF)

Expression profiling of primary non-small cell lung cancer for target identification

Oncogene, 2002-10, Vol.21 (50), p.7749-7763

2002

Volltextzugriff (PDF)

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Swiss medical weekly, 2015, Vol.145, p.w14100

2015

Volltextzugriff (PDF)

Eine Frühdiagnose verbessert das Überleben

Primary and hospital care (Deutsche Ausg. Internet), 2018-07

2018

Volltextzugriff (PDF)

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

Lung cancer (Amsterdam, Netherlands), 2012-12, Vol.78 (3), p.239-244

2012

Volltextzugriff (PDF)

Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial

Clinical lung cancer, 2017-05, Vol.18 (3), p.303-309

2017

Volltextzugriff (PDF)

Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions

Oncogene, 2003-11, Vol.22 (54), p.8677-8687

2003

Volltextzugriff (PDF)

Cerebral Nocardiosis Mimicking Multiple Brain Metastases in a Patient with Locally Advanced Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2014-03, Vol.9 (3), p.e24-e26

2014

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(80)
Humans
(75)
Oncology
(59)
Female
(46)
Male
(45)
Aged
(42)
Middle Aged
(41)
Biological And Medical Sciences
(37)
Adult
(32)
Medical Sciences
(30)
Respiratory System
(23)
Lung Neoplasms - Drug Therapy
(20)
Neoplasm Staging
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Carcinoma, Non-Small-Cell Lung - Pathology
(19)
Chemotherapy
(19)
Lung Neoplasms - Pathology
(19)
Treatment Outcome
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation

Comparison between opportunistic and organised breast cancer mammography screening in the Swiss canton of Fribourg

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Swiss Delphi study on iron deficiency

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Efficacy of Cetuximab in Metastatic Castration-Resistant Prostate Cancer Might Depend on EGFR and PTEN Expression: Results from a Phase II Trial (SAKK 08/07)

A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients

The stem cell gene “inhibitor of differentiation 1” (ID1) is frequently expressed in non-small cell lung cancer

Expression profiling of primary non-small cell lung cancer for target identification

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Eine Frühdiagnose verbessert das Überleben

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial

Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions

Cerebral Nocardiosis Mimicking Multiple Brain Metastases in a Patient with Locally Advanced Non–Small-Cell Lung Cancer

Suchergebnisse filtern